Some of the Directors have purchased shares in recent times which suggested they were pretty confident.
and that was after the hard lessons learned after the labcon fiasco. To now see Fuji now fallout is devastating for all.
And why a top pharma would be considering expansion to other labs when BCT is on the ropes and is down and arguably almost out is very confusing....
i am down way too much to talk of on this thing. where it goes to from here is .....?
Ann: BCT expansion order from Global Pharma client and Update, page-6
Add BCT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.001(20.0%) |
Mkt cap ! $7.092M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.6¢ | 0.5¢ | $5.54K | 1.090M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 4000250 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 3404453 | 5 |
View Market Depth
| Last trade - 13.13pm 19/07/2024 (20 minute delay) ? |
| BCT (ASX) Chart |